Cargando…
PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis
Prostaglandin E2 (PGE2), a major cyclooxygenase-2 (COX-2) product, is highly secreted by the osteoblast lineage in the subchondral bone tissue of osteoarthritis (OA) patients. However, NSAIDs, including COX-2 inhibitors, have severe side effects during OA treatment. Therefore, the identification of...
Autores principales: | Jiang, Wenhao, Jin, Yunyun, Zhang, Shiwei, Ding, Yi, Huo, Konglin, Yang, Junjie, Zhao, Lei, Nian, Baoning, Zhong, Tao P., Lu, Weiqiang, Zhang, Hankun, Cao, Xu, Shah, Karan Mehul, Wang, Ning, Liu, Mingyao, Luo, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904489/ https://www.ncbi.nlm.nih.gov/pubmed/35260562 http://dx.doi.org/10.1038/s41413-022-00201-4 |
Ejemplares similares
-
Inhibition of PGE2 in Subchondral Bone Attenuates Osteoarthritis
por: Sun, Qi, et al.
Publicado: (2022) -
A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration
por: Jin, Yunyun, et al.
Publicado: (2022) -
Noncoding RNAs in subchondral bone osteoclast function and their therapeutic potential for osteoarthritis
por: Duan, Li, et al.
Publicado: (2020) -
Osteoclasts secrete leukemia inhibitory factor to promote abnormal bone remodeling of subchondral bone in osteoarthritis
por: Zhao, Xin, et al.
Publicado: (2022) -
Vindoline Attenuates Osteoarthritis Progression Through Suppressing the NF-κB and ERK Pathways in Both Chondrocytes and Subchondral Osteoclasts
por: Zhu, Meisong, et al.
Publicado: (2022)